Our Work
Latham Advises on Inbiome’s US$16 Million Series A
April 17, 2026
Firm represents lead investor on funding round of molecular diagnostics company redefining microbiology testing.
Latham & Watkins has advised the NATO Innovation Fund (NIF) as a lead investor on the US$16 million Series A funding round of Inbiome, a Dutch molecular diagnostics company redefining microbiology testing.
The round was co-led by NIF and a consortium of investors led by Michiel Boehmer and Slingshot Ventures.
The Latham team was led by London corporate partner Shing Lo, with associates Toni Adejuyigbe and Kathleen Teo.